四、WTO上訴機構的最後一位成員任期於2020年11月30日到期,請問此一狀況對WTO的争端解決機制帶來哪些影響?(10%)WTO會員試圖採取哪些方式來面對WTO無上訴機構成員的困境?試舉出兩類因應方式(15%)。

(一) WTO下有關豁免的規定為何?(5%)

(二)TRIPS 協定針對強制授權的規 定為何?(20%)

二、於2020年上半年,許多 WTO員為了因應新冠肺炎,針對各類醫療與個人防護用品纷纷採取出口管制措施,包括出口關稅、出口限制或出口配額。請問此類措施於WTO下的法性?(20%

三、WTO规則中允許會員就其認為重要的公共政策訂定相關規範,但此類规範需具有必要性,請比較「必要性」以及相似的概念(not more trade-restrictive than necessary, not more trade-restrictive than required)於GATT、TBT 協定、以及SPS協定下的異同(20%)

(i) in its assessment of the facts of the matter, the panel shall determine whether the authorities' establishment of the facts was proper and whether their evaluation of those facts was unbiased and objective. If the establishment of the facts was proper and the evaluation was unbiased and objective, even though the panel might have reached a different conclusion, the evaluation shall not be overturned;

(ii) the panel shall interpret the relevant provisions of the Agreement in accordance with customary rules of interpretation of public international law. Where the panel finds that a relevant provision of the Agreement admits of more than one permissible interpretation, the panel shall find the authorities' measure to be in conformity with the Agreement if it rests upon one of those permissible interpretations. (5%)

2. The function of panels is to assist the DSB in discharging its responsibilities under this Understanding and the covered agreements. Accordingly, a panel should make an objective assessment of the matter before it, including an objective assessment of the facts of the case and the applicability of and conformity with the relevant covered agreements, and make such other findings as will assist the DSB in making the recommendations or in giving the rulings provided for in the covered agreements. Panels should consult regularly with the parties to the dispute and give them adequate opportunity to develop a mutually satisfactory solution. (5%)

(3) In order to facilitate access to medicines and vaccines in developing countries, some countries propose that WTO Members waive copyright, industrial designs, patents and undisclosed information related to COVID-19 medicines, vaccines, diagnostics and other technologies. (15%)

(2) Some countries apply import liberalization measures. For instance, suspending anti-dumping duties on plastic syringes or eliminate customs duties on medicines and medical equipment. (10%)

(1) Some countries adopt restrictive measures. For instance, border control, travel ban, export restrictions on medical supplies or food. (25%)

110年 - 110 國立政治大學_碩士班招生考試_ 國際經營與貿易學系/國際經貿法組:國際經貿法#102873

110年 - 110 國立臺灣大學_碩士班招生考系所_法律研究所庚組:國際經貿法#101252